Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 17, 2024
Date Accepted: May 2, 2025

The final, peer-reviewed published version of this preprint can be found here:

Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children With Neurogenetic Conditions (Project WellCAST): Protocol for a Randomized Controlled Trial

Kelleher B, Emerson K, Graham LN, Vozka V, Wheeler A, Fadel W, Foti D, Metzger I, Rispoli M, Machalicek W, McLay L, Lane S, Neo WS, Carter A, Brown L, Brown J, McIntyre LL, Salwitz E, Dietz G, Naughton R, Peek K, Hollins N, Woodford E

Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children With Neurogenetic Conditions (Project WellCAST): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2025;14:e64360

DOI: 10.2196/64360

PMID: 40560646

PMCID: 12237203

Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children with Neurogenetic Conditions: Protocol for Project WellCAST, a Randomized Controlled Trial

  • Bridgette Kelleher; 
  • Kaleb Emerson; 
  • Lyndsey N. Graham; 
  • Veronika Vozka; 
  • Anne Wheeler; 
  • William Fadel; 
  • Daniel Foti; 
  • Isha Metzger; 
  • Mandy Rispoli; 
  • Wendy Machalicek; 
  • Laurie McLay; 
  • Sean Lane; 
  • Wei Siong Neo; 
  • Allie Carter; 
  • Lisa Brown; 
  • Jennifer Brown; 
  • Laura Lee McIntyre; 
  • Elizabeth Salwitz; 
  • Gloria Dietz; 
  • Riley Naughton; 
  • Katlyn Peek; 
  • Nicole Hollins; 
  • Emma Woodford

ABSTRACT

Background:

Even prior to the COVID-19 pandemic, caregivers of children with rare neurogenetic conditions (NGC) experienced elevated physical and mental health challenges; these challenges further escalated during COVID-19 due to crisis-level breakdowns in support and intervention services. Telehealth mental health and parenting support services expanded rapidly in response to the COVID-19 pandemic and may be well-suited to facilitate necessary support interventions for parents of children with NGCs. However, it remains unclear how to match these evidence-based interventions to individual NGC caregivers’ needs.

Objective:

Project WellCAST (Addressing the WELLbeing of CAregiverS via Telehealth; NCT05999448) is an early-phase clinical trial designed to prospectively test which evidence-based telehealth interventions best meet the needs of NGC caregivers. Specifically, we develop and optimize a personalized health algorithm that matches caregivers to specific evidence-based telehealth support programs; we then test the feasibility and efficacy of algorithm-assigned treatment across four waves of data collection, relative to quasi-random assignment and waitlist controls. During each treatment wave, the personalized health algorithm relies on two weeks of baseline data collection using clinical tools and innovative smartphone-based ecological momentary assessments (EMA). Across waves, we also test the efficacy of a motivational peer-to-peer coaching protocol, deployed by trained NGC caregiver staff, in enhancing treatment uptake and clinical outcomes.

Methods:

Interested and eligible NGC caregivers are enrolled into a 24-week program with five phases, including baseline (2 weeks), treatment (12 weeks), and follow-up (2 weeks) periods; 4 week gaps separate phases. Caregivers participate in two randomizations: (1) treatment assignment via a precision health algorithm versus quasi-random assignment, and (2) motivational coaching by another NGC caregiver and project staff member (“peer coaching”) versus standard check-ins by a staff member who is not a NGC caregiver (“staff coaching”). Treatments include Acceptance and Commitment Therapy, Dialectical and Behavioral Therapy, Culturally-Informed Cognitive-Behavioral Therapy, Research Units in Behavioral Intervention, Naturalistic Communication Intervention, Durand Sleep Intervention, and self-guided resources. A subset of caregivers will participate as waitlist controls prior to treatment.

Results:

Four waves of data collection are scheduled for August 2023-September 2025. Pre-registered analyses will contrast feasibility, efficacy, and acceptability across algorithms and coaching assignment; multiple waves of data collection will allow us to continually optimize the algorithm and test incremental improvements across project phases. Secondary analyses will probe the feasibility and efficacy of individual evidence-based treatments and peer coaching.

Conclusions:

Project WellCAST will test whether a digital personalized health algorithm and peer coaching protocol can prospectively enhance telehealth treatment outcomes among NGC caregivers. This project is relevant to the specific population of NGC caregivers and may also inform how brief digital assessments, precision health tools, and community-academic partnerships can enhance public heath response to mental health crises across other high-need populations. Clinical Trial: NCT05999448; https://osf.io/8wndp


 Citation

Please cite as:

Kelleher B, Emerson K, Graham LN, Vozka V, Wheeler A, Fadel W, Foti D, Metzger I, Rispoli M, Machalicek W, McLay L, Lane S, Neo WS, Carter A, Brown L, Brown J, McIntyre LL, Salwitz E, Dietz G, Naughton R, Peek K, Hollins N, Woodford E

Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children With Neurogenetic Conditions (Project WellCAST): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2025;14:e64360

DOI: 10.2196/64360

PMID: 40560646

PMCID: 12237203

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.